|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0786 | (2010.01) |
| A61K 39/00 | (2006.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2992089 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14791480.8 |
| Date of filing the European patent application | 2014-04-23 | |
| (97) | Date of publication of the European application | 2016-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/035167 |
| Date | 2014-04-23 |
| (87) | Number | WO 2014/179132 |
| Date | 2014-11-06 |
| (30) | Number | Date | Country code |
| 201361817229 P | 2013-04-29 | US |
| (72) |
TSENG, Diane , US
VOLKMER, Jens-Peter , US
WEISKOPF, Kipp Andrew , US
WILLINGHAM, Stephen , US
WEISSMAN, Irving L. , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | USE OF ANTI-CD47 AGENTS TO ENHANCE IMMUNIZATION |
| USE OF ANTI-CD47 AGENTS TO ENHANCE IMMUNIZATION |